Residual TP53 Mutation Contributes to Chemoresistance through Clonal Expansion in Acute Myeloid Leukemia

被引：1
|
作者：
Yan, Bowen [1 ]
Chen, Qinwei [1 ]
Xu, Jianfeng [2 ]
Li, Wei [2 ]
Xu, Bing [3 ]
Huang, Suming [4 ]
Qiu, Yi [1 ]
机构：
[1] Univ Florida, Coll Med, Dept Anat & Cell Biol, Gainesville, FL USA
[2] Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA
[3] Xiamen Univ, Dept Hematol, Affiliated Hosp 1, Xiamen, Peoples R China
[4] Penn State Univ, Hershey Coll Med, Dept Pediat, Div Hematol & Oncol,Penn State Canc Inst, Hershey, PA USA
来源：
BLOOD | 2019年 / 134卷
关键词：
D O I：
10.1182/blood-2019-127511
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2731
引用
收藏
页数：3
相关论文
共 50 条
  • [21] TP53 Alterations in Myelodysplastic Syndromes and Acute Myeloid Leukemia
    Rahme, Ramy
    Braun, Thorsten
    Manfredi, James J.
    Fenaux, Pierre
    BIOMEDICINES, 2023, 11 (04)
  • [22] Functional Classification of TP53 Mutations in Acute Myeloid Leukemia
    Dutta, Sayantanee
    Pregartner, Gudrun
    Ruecker, Frank G.
    Heitzer, Ellen
    Zebisch, Armin
    Bullinger, Lars
    Berghold, Andrea
    Doehner, Konstanze
    Sill, Heinz
    CANCERS, 2020, 12 (03)
  • [23] The role of TP53 in acute myeloid leukemia: Challenges and opportunities
    Barbosa, Karina
    Li, Sha
    Adams, Peter D.
    Deshpande, Aniruddha J.
    GENES CHROMOSOMES & CANCER, 2019, 58 (12): : 875 - 888
  • [24] Impact of TP53 Mutated Subclones in Acute Myeloid Leukemia
    Pabst, Gabriel
    Prochazka, Katharina
    Pregartner, Gudrun
    Rucker, Frank G.
    Heitzer, Ellen
    Woelfler, Albert
    Zebisch, Armin
    Berghold, Andrea
    Dohner, Konstanze
    Sill, Heinz
    BLOOD, 2018, 132
  • [25] Elucidating the immune landscape and potential prognostic model in acute myeloid leukemia with TP53 mutation
    Zhu, Gelan
    Cai, Jiayi
    Fu, Wanbin
    Sun, Yue
    Wang, Ting
    Zhong, Hua
    HEMATOLOGY, 2024, 29 (01)
  • [26] Chidamide and Decitabine in Combination with a HAG Priming Regimen for Acute Myeloid Leukemia with TP53 Mutation
    Zhang, Bei
    Pei, Zhixin
    Wang, Hongxia
    Wu, Huimin
    Wang, Junjie
    Bai, Junjun
    Song, Qinglin
    ACTA MEDICA OKAYAMA, 2022, 76 (01) : 63 - 70
  • [27] COMPARISON TP53 MUTATION SITES IN BLAST PHASE OF MYELOPROLIFERATIVE NEOPLASM AND ACUTE MYELOID LEUKEMIA
    Chen, Dong
    Cantu, Miguel
    Siddon, Alexa
    Weinberg, Olga
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2024, 46 : 24 - 24
  • [28] TP53 Protein Expression, But Not 17p13 Deletion, is Useful in Rapid Screening and Triage of TP53 Mutation in Acute Myeloid Leukemia
    Nwaoduah, Nneamaka
    Bernabeu, Belen Quereda
    Wang, Zixuan
    Liu, Jinglan
    Uppal, Guldeep
    Peiper, Stephen
    Gong, Jerald
    MODERN PATHOLOGY, 2018, 31 : 541 - 541
  • [29] TP53 Protein Expression, But Not 17p13 Deletion, is Useful in Rapid Screening and Triage of TP53 Mutation in Acute Myeloid Leukemia
    Nwaoduah, Nneamaka
    Bernabeu, Belen Quereda
    Wang, Zixuan
    Liu, Jinglan
    Uppal, Guldeep
    Peiper, Stephen
    Gong, Jerald
    LABORATORY INVESTIGATION, 2018, 98 : 541 - 541
  • [30] Clinical implications of subclonal TP53 mutations in acute myeloid leukemia
    Prochazka, Katharina T.
    Pregartner, Gudrun
    Ruecker, Frank G.
    Heitzer, Ellen
    Pabst, Gabriel
    Woelfler, Albert
    Zebisch, Armin
    Berghold, Andrea
    Doehner, Konstanze
    Sill, Heinz
    HAEMATOLOGICA, 2019, 104 (03) : 516 - 523
12345